FDA Import Refusal SCS-0135650-1/11/2 — The Madras Pharmaceuticals
The FDA refused shipment SCS-0135650-1/11/2 from The Madras Pharmaceuticals (India) on Nov 2, 2018. The refused product falls under Drugs and Biologics — TELMISARTAN (ANTI-HYPERTENSIVE - PART II). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Nov 2, 2018
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 62ODA09 TELMISARTAN (ANTI-HYPERTENSIVE - PART II)
- Charges
- 75